000 | 01952 a2200601 4500 | ||
---|---|---|---|
005 | 20250518004830.0 | ||
264 | 0 | _c20190930 | |
008 | 201909s 0 0 eng d | ||
022 | _a1573-2592 | ||
024 | 7 |
_a10.1007/s10875-018-0565-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aArts, Katrijn | |
245 | 0 | 0 |
_aWarts and DADA2: a Mere Coincidence? _h[electronic resource] |
260 |
_bJournal of clinical immunology _c11 2018 |
||
300 |
_a836-843 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenosine Deaminase _xdeficiency |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAgammaglobulinemia _xdrug therapy |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
650 | 0 | 4 | _aAutoimmunity |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aEtanercept _xtherapeutic use |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHomozygote |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInflammation |
650 | 0 | 4 |
_aIntercellular Signaling Peptides and Proteins _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMutation _xgenetics |
650 | 0 | 4 | _aPedigree |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aSevere Combined Immunodeficiency _xdrug therapy |
650 | 0 | 4 |
_aSkin _xpathology |
650 | 0 | 4 |
_aWarts _xdrug therapy |
700 | 1 | _aBergerson, Jenna R E | |
700 | 1 | _aOmbrello, Amanda K | |
700 | 1 | _aSimiluk, Morgan | |
700 | 1 | _aOler, Andrew J | |
700 | 1 | _aAgharahimi, Anahita | |
700 | 1 | _aMace, Emily M | |
700 | 1 | _aHershfield, Mike | |
700 | 1 | _aWouters, Carine | |
700 | 1 | _aDe Somer, Lien | |
700 | 1 | _aMorren, Marie-Anne | |
700 | 1 | _aDiego, Rebeca Perez-de | |
700 | 1 | _aMoens, Leen | |
700 | 1 | _aFreeman, Alexandra F | |
700 | 1 | _aMeyts, Isabelle | |
773 | 0 |
_tJournal of clinical immunology _gvol. 38 _gno. 8 _gp. 836-843 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10875-018-0565-0 _zAvailable from publisher's website |
999 |
_c29003438 _d29003438 |